dodecyl maltoside: Clinical Trials

2 trials of dodecyl maltoside, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1

Follow dodecyl maltoside: new trials by email Literature Review of dodecyl maltoside trials Research Report on dodecyl maltoside

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin
Cretostimogene Grenadenorepvec, n-dodecyl-B-D-maltoside - Non Muscle Invasive Bladder Cancer, High-grade Ta/ T1 Papillary Disease Bladder Cancer
Phase 2RecruitingLepu Biopharma Co., Ltd.162025-12-042026-04-23
Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin
CG0070, Pembrolizumab Injection, n-dodecyl-B-D-maltoside - Non Muscle Invasive Bladder Cancer
Phase 2CompletedCG Oncology, Inc.352020-12-082024-09-25

Conditions studied

Carcinoma in Situ (2)  ·  Non-Muscle Invasive Bladder Neoplasms (2)

Sponsors

CG Oncology, Inc. (1)  ·  Lepu Biopharma Co., Ltd. (1)

Countries

China (1)  ·  South Korea (1)  ·  United States (1)

Results publications

PMID 38844794